Azione ORIA ORION BIOTECH OPPORTUNITIES CORP.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati
Strumento inattivo

Altre lingue Orion Biotech Opportunities Corp.

Azioni

ORIA

KYG6780C1096

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Orion Biotech Opportunities Corp.(OTCPK:ORIA) dropped from NASDAQ Composite Index
Orion Biotech Opportunities : will redeem its Public Shares and will not consummate an initial business combination - Form 8-K
ORION BIOTECH OPPORTUNITIES CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Orion Biotech Opportunities Corp. Auditor Raises 'Going Concern' Doubt
Orion Biotech Opportunities Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Orion Biotech Opportunities Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Orion Biotech Opportunities Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Orion Biotech Opportunities Corp. Reports Earnings Results for the Eleven Months Ended December 31, 2021
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
ORION BIOTECH OPPORTUNITIES CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Certain Class B Ordinary Shares of Orion Biotech Opportunities Corp. are subject to a Lock-Up Agreement Ending on 9-NOV-2021.
ORION BIOTECH OPPORTUNITIES : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Orion Biotech Opportunities Corp. has completed an IPO in the amount of $200 million.
Orion Biotech Opportunities Corp. has filed an IPO in the amount of $200 million.
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione ORIA
  4. Notizie Orion Biotech Opportunities Corp.
  5. Altre lingue